- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (148)
- Timeline of Article Publication (1)
- Authors Evaluation (3)
- Article Quality Tracking (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6023)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 14, 2024 (publication date) through Sep 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Maity R, Dhali A, Biswas J. Is Helicobacter pylori infection protective against esophageal cancer? World J Gastroenterol 2024; 30(38): 4168-4174 [PMID: 39493327 DOI: 10.3748/wjg.v30.i38.4168] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i38/4168.htm |
| Number | Citing Articles |
| 1 |
He Xin, Chi Zhu, Chan Zhu, Xing Zhang, Dongsheng Chen, Qingping Wang. Beyond the stomach: the association between Helicobacter pylori and the spectrum of digestive cancers. Frontiers in Cellular and Infection Microbiology 2025; 15 doi: 10.3389/fcimb.2025.1633227
|
| 2 |
Ahan Bhatt, Hasan Musanna Zaidi, Radhashree Maitra, Sanjay Goel. Infectious Agents and Esophageal Cancer: A Comprehensive Review. Cancers 2025; 17(7): 1248 doi: 10.3390/cancers17071248
|
| 3 |
Liza Eiman, Khadija Moazzam, Sumaira Anjum, Humera Kausar, Elham Abdullatif M. Sharif, Wisam Nabeel Ibrahim. Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1575452
|